aMoon
Israeli healthcare and life sciences venture fund co-founded by Marius Nacht (Check Point co-founder). One of the largest healthcare funds in Israel, investing globally in transformative healthcare companies.
Website
https://www.amoon.comLocation
Tel Aviv, Israel
Founded
2016
AUM
$1.3B+
Investment Range
$10M - $100M
Portfolio Companies
8
Focus
biotech-focused
Fund Stages
series-a, series-b, series-c, growth
Investment Thesis
aMoon invests in transformative healthcare and life sciences companies globally, with particular expertise in Israeli innovation. They focus on companies with breakthrough technologies that can significantly improve patient outcomes, leveraging their deep network in the Israeli tech and life sciences ecosystem.
Team
Partners / Managing Directors (Health & Bio Focus)
- Marius Nacht - Co-Founder & Chairman
- Yair Schindel, MD - Co-Founder & Managing Partner
- Zohar Yinon - Partner
Other Key Team Members
- Orit Hashay - Partner
Focus Areas
- Digital Health
- Therapeutics
- Medical Devices
- Diagnostics
- Healthcare AI
- Genomics
- Life Sciences
Notable Exits
- Zebra Medical Vision - Acquired (2021, by Nanox for $200M)
- Healthy.io - Multiple funding rounds, continued growth
- Ultima Genomics - $600M funding round participant (2022)
Sources
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Ultima Genomics | Fremont, California, USA | 2016 | genomics-sequencingbiotech+1 |
| Advaxis | Princeton, New Jersey, USA | 2002 | biotechimmunotherapy+2 |
| Omada Health | San Francisco, California, USA | 2011 | digital-healthchronic-disease+3 |
| Seer | Redwood City, California, USA | 2017 | proteomicsbiomarkers+3 |
| Sera Prognostics | Salt Lake City, Utah, USA | 2008 | womens-healthdiagnostics+3 |
| SOPHiA GENETICS | Lausanne, Switzerland | 2011 | genomicsdata-driven-medicine+3 |
| Viracta Therapeutics | San Diego, California, USA | 2016 | biotechoncology+3 |